A biotechnology company applying cellular technology in neuro-scientific regenerative medicine.

, a biotechnology company applying cellular technology in neuro-scientific regenerative medicine, announced today that organization Chairman and CEO, William M. Caldwell, IV, today at the 7th Insurance Connected Securities Summit will end up being providing a luncheon keynote address, being held January 27-29, 2010 at the Roosevelt Hotel in New York City. This annual gathering includes the entire worth chain for both life and non-life markets, including institutional traders, hedge funds, reinsurance and insurance companies, life insurance settlement providers, underwriters, lawyers, and banks. Mr. Caldwell will be delivering a demonstration titled, The Evolving Parameters of Individual Longevity: Biotech Perspectives on the power of Medical Technology to improve the Human Lifespan.Related StoriesExpanded make use of for IntelliCap with additional CE Tag for aspiration of fluidsBRCA gene mutations and ovarian cancer tumor: an interview with Dr Matulonis, Harvard Medical SchoolAddressing standard of living needs in prostate cancers: an interview with Professor Louis Denis.. Article suggests socially-based strategy for treating Alzheimer’s, other cognitive disorders Is treating Alzheimer's Disease and other Ageing Associated Cognitive Problems through medical models actually the most effective response to diagnoses? In this article ‘The Issues of Cognitive Aging: Integrating Techniques from Neuroscience to Intergenerational Relationships,’ published in the Journal of Intergenerational Associations, writer Peter Whitehouse suggests a far more socially-based approach to treating Alzheimer's and other cognitive disorders.